CXCR2 and chronic obstructive pulmonary disease: CXCR2 antagonists are under investigation as anti-inflammatory therapeutics in a variety of disease states including chronic obstructive pulmonary disorder (COPD), type I diabetes, rheumatoid arthritis, ulcerative colitis, and cancer [70].